Adios to Termeer? Icahn Tries to Replace 4 Directors at Genzyme

Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals

Biopharma groups seek changes to FDA’s innovative manufacturing strategy

Sanofi CD38 antibody delivers in phase 3 trial

Pfizer to let go of 791 employees at NJ site